1) 山縣俊之,一ノ瀬正和:COPDの炎症―exhaled breath condensateの解析より.分子呼吸器病 8:36-43,2004
2) 戸蒔雅文,一ノ瀬正和:新しい気道炎症の評価法―呼気凝集液(exhaled breath condensate).呼吸器科 1:392-397,2002
3) MacNee W, Rahman I:Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50:S53-58,1995
4) Behr J, Degenkolb B, Krombach F, et al:Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis:effects of N-acetylcysteine. Eur Respir J 19:906-911,2002
5) Demedts M, Behr J, Buhl R, et al:High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229-2242,2005
6) Meyer A, Buhl R, Magnussen H:The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 7:431-436,1994
7) Meyer A, Buhl R, Kampf S, et al:Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 152:1055-1060,1995
8) Tomioka H, Kuwata Y, Imanaka K, et al:A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis. Respirology 10:449-455,2005
9) Mata M, Ruz A, Cerda M, et al:Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J 22:900-905,2003
10) Serrano-Mollar A, Closa D, Prats N, et al:In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 138:1037-1048,2003
11) Pardo A, Ruiz V, Arreola JL, et al:Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. Am J Respir Crit Care Med 167:925-932,2003(Epub 2002 Dec 4)
12) 本間栄:早期特発性肺線維症に対するN-アセチルシステイン吸入療法に関する前向き多施設共同治療研究.厚生労働科学研究「特発性間質性肺炎の画期的治療法に関する臨床研究」事業 2005年報告書,2005